Annual D&A
$10.97 M
+$345.00 K+3.25%
31 December 2023
Summary:
NovoCure Limited annual depreciation & amortization is currently $10.97 million, with the most recent change of +$345.00 thousand (+3.25%) on 31 December 2023. During the last 3 years, it has risen by +$1.82 million (+19.88%). NVCR annual D&A is now at all-time high.NVCR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$2.46 M
-$400.00 K-14.00%
30 September 2024
Summary:
NovoCure Limited quarterly depreciation & amortization is currently $2.46 million, with the most recent change of -$400.00 thousand (-14.00%) on 30 September 2024. Over the past year, it has dropped by -$345.00 thousand (-12.31%). NVCR quarterly D&A is now -14.00% below its all-time high of $2.86 million, reached on 30 June 2024.NVCR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$10.85 M
-$345.00 K-3.08%
30 September 2024
Summary:
NovoCure Limited TTM depreciation & amortization is currently $10.85 million, with the most recent change of -$345.00 thousand (-3.08%) on 30 September 2024. Over the past year, it has dropped by -$92.00 thousand (-0.84%). NVCR TTM D&A is now -3.08% below its all-time high of $11.20 million, reached on 30 June 2024.NVCR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCR Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.3% | -12.3% | -0.8% |
| 3 y3 years | +19.9% | -10.1% | +7.9% |
| 5 y5 years | +21.8% | +27.2% | +32.4% |
NVCR Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +19.9% | -14.0% | at low | -3.1% | +7.9% |
| 5 y | 5 years | at high | +29.7% | -14.0% | +30.2% | -3.1% | +32.4% |
| alltime | all time | at high | +802.1% | -14.0% | +369.1% | -3.1% | +1971.4% |
NovoCure Limited Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.46 M(-14.0%) | $10.85 M(-3.1%) |
| June 2024 | - | $2.86 M(+1.5%) | $11.20 M(+1.2%) |
| Mar 2024 | - | $2.81 M(+3.4%) | $11.06 M(+0.8%) |
| Dec 2023 | $10.97 M(+3.2%) | $2.72 M(-2.9%) | $10.97 M(+0.2%) |
| Sept 2023 | - | $2.80 M(+3.0%) | $10.95 M(+1.3%) |
| June 2023 | - | $2.72 M(-0.0%) | $10.80 M(+0.6%) |
| Mar 2023 | - | $2.72 M(+0.8%) | $10.74 M(+1.1%) |
| Dec 2022 | $10.62 M(+3.6%) | $2.70 M(+1.5%) | $10.62 M(+0.3%) |
| Sept 2022 | - | $2.66 M(+0.2%) | $10.59 M(-0.7%) |
| June 2022 | - | $2.65 M(+1.7%) | $10.66 M(+1.7%) |
| Mar 2022 | - | $2.61 M(-2.1%) | $10.49 M(+2.3%) |
| Dec 2021 | $10.25 M(+12.0%) | $2.67 M(-2.5%) | $10.25 M(+1.9%) |
| Sept 2021 | - | $2.73 M(+10.2%) | $10.06 M(+5.7%) |
| June 2021 | - | $2.48 M(+4.6%) | $9.51 M(-1.3%) |
| Mar 2021 | - | $2.37 M(-4.2%) | $9.63 M(+5.3%) |
| Dec 2020 | $9.15 M(+8.2%) | $2.47 M(+13.0%) | $9.15 M(+0.1%) |
| Sept 2020 | - | $2.19 M(-15.9%) | $9.14 M(+2.9%) |
| June 2020 | - | $2.60 M(+37.8%) | $8.89 M(+5.6%) |
| Mar 2020 | - | $1.89 M(-23.5%) | $8.42 M(-0.5%) |
| Dec 2019 | $8.46 M | $2.47 M(+27.7%) | $8.46 M(+3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $1.93 M(-9.4%) | $8.20 M(-4.4%) |
| June 2019 | - | $2.13 M(+10.5%) | $8.58 M(-1.8%) |
| Mar 2019 | - | $1.93 M(-12.5%) | $8.73 M(-3.0%) |
| Dec 2018 | $9.01 M(+17.3%) | $2.21 M(-4.6%) | $9.01 M(+0.6%) |
| Sept 2018 | - | $2.31 M(+1.0%) | $8.95 M(+3.0%) |
| June 2018 | - | $2.29 M(+3.8%) | $8.70 M(+5.8%) |
| Mar 2018 | - | $2.20 M(+2.3%) | $8.22 M(+7.1%) |
| Dec 2017 | $7.68 M(+35.8%) | $2.15 M(+4.9%) | $7.68 M(+7.9%) |
| Sept 2017 | - | $2.05 M(+13.4%) | $7.11 M(+7.6%) |
| June 2017 | - | $1.81 M(+9.1%) | $6.61 M(+6.5%) |
| Mar 2017 | - | $1.66 M(+4.5%) | $6.21 M(+9.9%) |
| Dec 2016 | $5.65 M(+79.3%) | $1.59 M(+2.3%) | $5.65 M(+8.5%) |
| Sept 2016 | - | $1.55 M(+10.4%) | $5.21 M(+14.5%) |
| June 2016 | - | $1.41 M(+27.6%) | $4.55 M(+21.9%) |
| Mar 2016 | - | $1.10 M(-3.9%) | $3.73 M(+18.4%) |
| Dec 2015 | $3.15 M(+60.7%) | $1.15 M(+28.6%) | $3.15 M(+57.3%) |
| Sept 2015 | - | $893.00 K(+51.9%) | $2.00 M(+80.3%) |
| June 2015 | - | $588.00 K(+12.2%) | $1.11 M(+112.2%) |
| Mar 2015 | - | $524.00 K | $524.00 K |
| Dec 2014 | $1.96 M(+61.3%) | - | - |
| Dec 2013 | $1.22 M | - | - |
FAQ
- What is NovoCure Limited annual depreciation & amortization?
- What is the all time high annual D&A for NovoCure Limited?
- What is NovoCure Limited annual D&A year-on-year change?
- What is NovoCure Limited quarterly depreciation & amortization?
- What is the all time high quarterly D&A for NovoCure Limited?
- What is NovoCure Limited quarterly D&A year-on-year change?
- What is NovoCure Limited TTM depreciation & amortization?
- What is the all time high TTM D&A for NovoCure Limited?
- What is NovoCure Limited TTM D&A year-on-year change?
What is NovoCure Limited annual depreciation & amortization?
The current annual D&A of NVCR is $10.97 M
What is the all time high annual D&A for NovoCure Limited?
NovoCure Limited all-time high annual depreciation & amortization is $10.97 M
What is NovoCure Limited annual D&A year-on-year change?
Over the past year, NVCR annual depreciation & amortization has changed by +$345.00 K (+3.25%)
What is NovoCure Limited quarterly depreciation & amortization?
The current quarterly D&A of NVCR is $2.46 M
What is the all time high quarterly D&A for NovoCure Limited?
NovoCure Limited all-time high quarterly depreciation & amortization is $2.86 M
What is NovoCure Limited quarterly D&A year-on-year change?
Over the past year, NVCR quarterly depreciation & amortization has changed by -$345.00 K (-12.31%)
What is NovoCure Limited TTM depreciation & amortization?
The current TTM D&A of NVCR is $10.85 M
What is the all time high TTM D&A for NovoCure Limited?
NovoCure Limited all-time high TTM depreciation & amortization is $11.20 M
What is NovoCure Limited TTM D&A year-on-year change?
Over the past year, NVCR TTM depreciation & amortization has changed by -$92.00 K (-0.84%)